RECRUITINGINTERVENTIONAL
DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial
About This Trial
This randomized controlled trial will assess the impact of the FoodSwitch mobile app, which provides interpretive front-of-pack labelling via barcode scanning, in 900 Swedish adults with type 2 diabetes. Participants will be randomized to app + standard advice or standard advice alone. The primary outcome is change in HbA1c at 6 months; secondary outcomes include anthropometrics, quality of life, medication use, hospitalizations, and mortality.
Who May Be Eligible (Plain English)
Who May Qualify:
- Age between 18 and 75 years
- Self-reported type 2 diabetes with a duration of ≥2 years
- Regularly grocery shopping
Who Should NOT Join This Trial:
- No access to BankID (a digital identification system commonly used in Sweden)
- Failure to complete eligibility screening and run-in periods
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion criteria:
* Age between 18 and 75 years
* Self-reported type 2 diabetes with a duration of ≥2 years
* Regularly grocery shopping
Exclusion criteria:
* No access to BankID (a digital identification system commonly used in Sweden)
* Failure to complete eligibility screening and run-in periods
Treatments Being Tested
OTHER
FoodSwitch
Access to the 'DiabetesSwitch' filter of the FoodSwitch app when grocery shopping. When a packaged food item bar code is scanned, the FoodSwitch app will show an interpretive nutritional information score for the scanned product and recommend alternate healthier food options in the same category.
Locations (1)
Linköping University
Linköping, Sweden